APA (7th ed.) Citation

SH, Y., HL, L., DU, J., KM, L., SJ, P., & KS, K. (2023). Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA). Frontiers in pharmacology, 14, 1220796. https://doi.org/10.3389/fphar.2023.1220796

Chicago Style (17th ed.) Citation

SH, Yoon, Lee HL, Jeong DU, Lim KM, Park SJ, and Kim KS. "Assessment of the Proarrhythmic Effects of Repurposed Antimalarials for COVID-19 Treatment Using a Comprehensive in Vitro Proarrhythmia Assay (CiPA)." Frontiers in Pharmacology 14 (2023): 1220796. https://doi.org/10.3389/fphar.2023.1220796.

MLA (9th ed.) Citation

SH, Yoon, et al. "Assessment of the Proarrhythmic Effects of Repurposed Antimalarials for COVID-19 Treatment Using a Comprehensive in Vitro Proarrhythmia Assay (CiPA)." Frontiers in Pharmacology, vol. 14, 2023, p. 1220796, https://doi.org/10.3389/fphar.2023.1220796.